NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024
It could be unnecessary, premature, or genuinely counterproductive depending on your situation
For more information, please visit www.northstrivebio.com
Anyone with specific metabolic health concerns should consult with a healthcare provider about appropriate options, which may include prescription medications where clinically indicated
Night Shred GLP-1: Take 2 capsules approximately 30 minutes before bedtime
Repeated freezing and thawing will damage the activity of the peptide